A Horizon Scan of Neurotechnology Innovations

Area of Science:

• Neuroscience
• Biomedical Engineering
• Healthcare Technology

Background:

• Neurotechnology presents immense healthcare opportunities but raises ethical and regulatory concerns.
• Responsible development and regulation are crucial for emerging neurotechnologies.

Purpose of the Study:

• To conduct a horizon scan of neurotechnologies in development and FDA-approved as of June 2024.
• To cover conditions related to mental health, healthy aging, and physical disability.

Main Methods:

• Searched clinical trials, conferences, journals, and news in March 2024.
• Identified relevant neurotechnologies through screening, data extraction, and synthesis.

Main Results:

• Identified 81 unique neurotechnologies: 23 for mental health, 31 for healthy aging, and 42 for physical disability.
• 79% lacked FDA approval; 77.4% were in early development (pilot/feasibility).
• Digital components were common; only three incorporated AI.

Conclusions:

• The neurotechnology field is nascent, with most technologies in early development and awaiting regulatory approval.
• The complex regulatory and ethical landscape presents challenges and opportunities for responsible innovation.
• Addressing ethical and safety concerns proactively is vital for the future of neurotechnology in healthcare.